Advances in Chronic Kidney Disease
Volume 15, Issue 2 , Pages 147-152 , April 2008

Racial and Ethnic Differences in Trends of End-Stage Renal Disease: United States, 1995 to 2005

References 

  1. U.S. Renal Data System: USRDS 2007 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2007. Available at: http://www.usrds.org/2007/pdf/02_incid_prev_07.pdf. Accessed October 4, 2007
  2. Centers for Disease Control and Prevention: National Diabetes Surveillance System. Available at: http://www.cdc.gov/diabetes/statistics/index.htm. Accessed October 26, 2007
  3. Ong KL, Cheung BM, Man YB, et al. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999–2004. Hypertension. 2007;49:69–75
  4. U.S. Renal Data System: Researcher's Guide to the USRDS Database. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2006;
  5. Surveillance Research Program of the US National Cancer Institute: Joinpoint Regression Program version 3.0. Available at: http://srab.cancer.gov/joinpoint/. Accessed July 9, 2007
  6. Kim HJ, Fay MP, Feuer EJ, et al. Permutation tests for joinpoint regression with application to cancer rates. Stat Med. 2000;19:335–351
  7. Centers for Disease Control and Prevention . Diabetes prevalence among American Indians and Alaska Natives and the overall population–United States, 1994–2002. MMWR Morb Mortal Wkly Rep. 2003;52:702–704
  8. Centers for Disease Control and Prevention . Incidence of end-stage renal disease among persons with diabetes–United States, 1990–2002. MMWR Morb Mortal Wkly Rep. 2005;54:1097–1100
  9. Centers for Disease Control and Prevention . Racial/ethnic disparities in prevalence, treatment, and control of hypertension–United States, 1999–2002. MMWR Morb Mortal Wkly Rep. 2005;54:7–9
  10. Ostchega Y, Dillon CF, Hughes JP, et al. Trends in hypertension prevalence, awareness, treatment, and control in older U.S. adults: Data from the National Health and Nutrition Examination Survey 1988 to 2004. J Am Geriatr Soc. 2007;55:1056–1065
  11. U.S. Department of Health and Human Services: Objectives for Improving Health: Chronic Kidney Disease, in Healthy People 2010 (ed 2). With Understanding and Improving Health and Objectives for Improving Health. Washington, DC, U.S. Government Printing Office, November 2000. Available at: http://www.healthypeople.gov/Document/HTML/Volume1/04CKD.htm. Accessed August 29, 2007
  12. Centers for Disease Control and Prevention . National diabetes fact sheet: general information and national estimates on diabetes in the United States, 2005. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2005;
  13. Rosamond W, Flegal K, Furie K, et al. Heart Disease and Stroke Statistics—2008 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2008;117:e25–e146
  14. Geiss LS, Rolka DB, Engelgau MM. Elevated blood pressure among U.S. adults with diabetes, 1988–1994. Am J Prev Med. 2002;22:43–49
  15. U.K. Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. UKPDS 33. Lancet. 1998;352:837–853
  16. U.K. Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes. UKPDS 38. BMJ. 1998;317:703–713
  17. Saaddine JB, Cadwell B, Gregg EW, et al. Improvements in diabetes processes of care and intermediate outcomes: United States, 1988–2002. Ann Intern Med. 2006;144:465–474
  18. Imperatore G, Cadwell BL, Geiss L, et al. Thirty-year trends in cardiovascular risk factor levels among U.S. adults with diabetes: National Health and Nutrition Examination Surveys, 1971–2000. Am J Epidemiol. 2004;160:531–539
  19. Parving HH, Hovind P. Microalbuminuria in type 1 and type 2 diabetes mellitus: Evidence with angiotensin converting enzyme inhibitors and angiotensin II receptor blockers for treating early and preventing clinical nephropathy. Curr Hypertens Rep. 2002;4:387–393
  20. Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298:2038–2047
  21. Hsu CY, Lin F, Vittinghoff E, et al. Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States. J Am Soc Nephrol. 2003;14:2902–2907
  22. Centers for Disease Control and Prevention: Kidney Disease Initiative. Available at: http://www.cdc.gov/diabetes/projects/kidney.htm. Accessed October 26, 2007
  23. Schoolwerth AC, Engelgau MM, Hostetter TH, et al: Chronic kidney disease: a public health problem that needs a public health action plan Prev Chronic Dis 3: A57, 2006. Available at: http://www.cdc.gov/pcd/issues/2006/apr/05_0105.htm. Accessed February 12, 2008
  24. Hostetter TH, Lising M. National Kidney Disease Education Program. J Natl Med Assoc. 2002;94(suppl):72S–75S
  25. National Institutes of Health: National Kidney Disease Education Program. Available at: http://www.nkdep.nih.gov/. Accessed December 9, 2007
  26. National Kidney Foundation: The National Kidney Foundation Kidney Disease Outcomes Quality Initiative. Available at: http://www.kidney.org/professionals/KDOQI/. Accessed December 9, 2007

 The data reported here have been supplied by the United States Renal Data System (USRDS). The interpretation and reporting of these data are the responsibility of the authors and in no way should be seen as an official policy or interpretation of the U.S. government.

PII: S1548-5595(08)00003-7

doi: 10.1053/j.ackd.2008.01.002

Advances in Chronic Kidney Disease
Volume 15, Issue 2 , Pages 147-152 , April 2008

Article Tools

* Image Usage & Resolution